We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

90 hedge funds and large institutions have $396M invested in TG Therapeutics in 2015 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 47 increasing their positions, 21 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 7

124% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 21

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

19% more capital invested

Capital invested by funds: $332M → $396M (+$63.7M)

18% more call options, than puts

Call options by funds: $4.12M | Put options by funds: $3.5M

14% more funds holding

Funds holding: 79 → 90 (+11)

Holders
90
Holders Change
+11
Holders Change %
+13.92%
% of All Funds
2.42%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
18
Increased
47
Reduced
21
Closed
7
Calls
$4.12M
Puts
$3.5M
Net Calls
+$615K
Net Calls Change
-$1.65M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$12.9M
2
State Street
State Street
Massachusetts
+$6.72M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$6.23M
4
SAM
Sectoral Asset Management
Quebec, Canada
+$5.32M
5
RCM
RA Capital Management
Massachusetts
+$2.8M

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$12.2M
2
BM
Bridger Management
New York
-$8.14M
3
HH
HWG Holdings
Texas
-$1.74M
4
Invesco
Invesco
Georgia
-$1.71M
5
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$1.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$2.08M +$655K +41,382 +49%
RFC
27
Russell Frank Company
Washington
$1.98M +$62.7K +3,958 +3%
TCIM
28
TIAA CREF Investment Management
New York
$1.95M +$489K +30,855 +35%
Ameriprise
29
Ameriprise
Minnesota
$1.61M +$399K +25,216 +35%
Deutsche Bank
30
Deutsche Bank
Germany
$1.38M -$650K -41,074 -33%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$1.35M +$317K +19,996 +33%
CS
32
Credit Suisse
Switzerland
$1.35M +$875K +55,265 +213%
FAM
33
Fred Alger Management
New York
$1.33M +$118K +7,450 +10%
PAMU
34
Pictet Asset Management (UK)
United Kingdom
$1.21M +$318K +20,100 +41%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$1.07M +$183K +11,562 +22%
AQR Capital Management
36
AQR Capital Management
Connecticut
$1.05M +$215K +13,560 +27%
Group One Trading
37
Group One Trading
Illinois
$1.01M +$399K +25,214 +71%
Morgan Stanley
38
Morgan Stanley
New York
$988K -$244K -15,387 -21%
TA
39
Teachers Advisors
New York
$857K +$208K +13,117 +34%
AllianceBernstein
40
AllianceBernstein
Tennessee
$833K +$583K +36,800 +275%
Charles Schwab
41
Charles Schwab
California
$826K +$137K +8,650 +21%
HT
42
HAP Trading
New York
$761K +$226K +14,301 +45%
Goldman Sachs
43
Goldman Sachs
New York
$714K +$277K +17,501 +68%
BGA
44
Belmont Global Advisors
Texas
$664K +$633K +40,000 New
Citadel Advisors
45
Citadel Advisors
Florida
$602K -$434K -27,390 -43%
Bank of America
46
Bank of America
North Carolina
$599K +$527K +33,274 +1,165%
Swiss National Bank
47
Swiss National Bank
Switzerland
$579K – – –
PPA
48
Parametric Portfolio Associates
Washington
$561K +$535K +33,808 New
Millennium Management
49
Millennium Management
New York
$557K -$545K -34,390 -51%
Creative Planning
50
Creative Planning
Kansas
$555K +$127K +8,000 +31%
1
2
3 4

TGTX Hedge Fund Activity: Q2 2015 in Review

90 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q2 2015, worth a combined $396M — up 19% from $332M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new TGTX positions and 7 closed out — a net gain of 11 holders — while 47 added to existing stakes and 21 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $12.9M. The largest seller was Visium Asset Management, cutting an estimated $12.2M.

  • 90 institutional investors held TG Therapeutics (TGTX) as of Q2 2015, up from 79 in Q1 2015.
  • Funds reported $396M of TG Therapeutics stock for Q2 2015, up 19% quarter-over-quarter.
  • 18 funds opened new TG Therapeutics positions in Q2 2015 and 7 closed out, a net change of +11 holders.
  • The largest TG Therapeutics buyer in Q2 2015 was Fidelity Investments, an estimated $12.9M added.
  • The largest TG Therapeutics seller in Q2 2015 was Visium Asset Management, an estimated $12.2M sold.

Based on aggregated 13F filings for Q2 2015.